publication date: Jun. 29, 2018

In Brief

Case Comprehensive Cancer Center earns “exceptional” rating, $31.9M in NCI grants

Case Comprehensive Cancer Center has earned NCI’s highest rating and $31.9 million in grants.

The “exceptional” rating comes as the Case Comprehensive Cancer Center—a collaboration among Case Western Reserve University, Cleveland Clinic and University Hospitals—celebrates its 30th anniversary.

The NCI review recognized Stanton Gerson, the Asa and Patricia Shiverick-Jane Shiverick (Tripp) Professor of Hematological Oncology at Case Western Reserve and the cancer center’s director since 2004, for his leadership and for developing such initiatives implementing a strategic-planning effort and enhanced transdisciplinary collaborations, establishing the Office of Cancer Disparities Research and recruiting talented new senior leaders and researchers.

The review also praised the center for continuing to be a research leader in basic, clinical and population sciences, and for providing exemplary service to the population in Northeast Ohio. The center has built a national reputation for research in colorectal cancers, leukemia and myelodysplastic syndrome, brain, lung, kidney and prostate cancers.

Combined, Cleveland Clinic and University Hospitals treat nearly 16,000 new cancer patients each year. Because these hospitals are part of an NCI-designated comprehensive cancer center, these patients have greater opportunities to participate in a broad range of clinical trials; they also benefit from the concentration of expertise among the three organizations.

As part of the review and designation, NCI approved the renewal of a five-year, $27.9 million (P30) grant to support collaborative research.

The center was also praised for its training, education and career-development programs for cancer trainees, from high school through junior faculty. Simultaneously, NCI awarded the center a $4 million Paul Calabrese Clinical Oncology Scholar … Continue reading Case Comprehensive Cancer Center earns “exceptional” rating, $31.9M in NCI grants

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.